Both in Pharmaceuticals
Phibro Animal Health vs Ultragenyx Pharmaceutical
Over the past year PAHC returned −10.4% and RARE returned −51.9%; their daily moves had a correlation of 0.08.
PAHC −10.4% RARE −51.9%Growth of $1, one year, split-adjusted
| Metric | PAHC | RARE |
|---|---|---|
| Price | $38.88 | $16.10 |
| Market cap | $1.58B | $1.59B |
| Today | +0.05% | −4.05% |
| 1 month | +8.4% | +9.2% |
| 6 months | −29.2% | −35.0% |
| Year to date | +4.1% | −30.0% |
| 1 year | −5.6% | −53.5% |
| Revenue growth (YoY) | +4.8% | +28.1% |
| Gross margin | 33.9% | 84.1% |
| Net margin | 5.5% | −43.0% |
| P/E (TTM) | 15.8× | — |
| Price / sales | 1.0× | 2.2× |
| Net cash | -$650.8M | $292.0M |
| Dividend yield | 1.23% | — |
| Volatility (60d) | 30.4% | 128.4% |
| Short % of float | 4.9% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).